RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Fundamental Analysis & Valuation

TSX-V:RHT • CA75955T1030

Current stock price

0.215 CAD
0 (0%)
Last:

This RHT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. RHT.CA Profitability Analysis

1.1 Basic Checks

  • RHT had negative earnings in the past year.
  • RHT had a negative operating cash flow in the past year.
RHT.CA Yearly Net Income VS EBIT VS OCF VS FCFRHT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

  • RHT has a better Return On Assets (-2.05%) than 75.00% of its industry peers.
  • The Return On Equity of RHT (-3.41%) is better than 87.50% of its industry peers.
Industry RankSector Rank
ROA -2.05%
ROE -3.41%
ROIC N/A
ROA(3y)-277.14%
ROA(5y)-257.7%
ROE(3y)-803.99%
ROE(5y)-598.14%
ROIC(3y)N/A
ROIC(5y)N/A
RHT.CA Yearly ROA, ROE, ROICRHT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K -10K

1.3 Margins

  • RHT's Gross Margin of 60.61% is in line compared to the rest of the industry. RHT outperforms 50.00% of its industry peers.
  • RHT's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for RHT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y143.2%
GM growth 5Y26.85%
RHT.CA Yearly Profit, Operating, Gross MarginsRHT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RHT.CA Health Analysis

2.1 Basic Checks

  • RHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RHT has been increased compared to 1 year ago.
  • RHT has a better debt/assets ratio than last year.
RHT.CA Yearly Shares OutstandingRHT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
RHT.CA Yearly Total Debt VS Total AssetsRHT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

  • RHT has an Altman-Z score of 0.13. This is a bad value and indicates that RHT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RHT (0.13) is better than 62.50% of its industry peers.
  • RHT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.01, RHT belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC9.53%
RHT.CA Yearly LT Debt VS Equity VS FCFRHT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 1.86 indicates that RHT should not have too much problems paying its short term obligations.
  • RHT has a Current ratio of 1.86. This is amongst the best in the industry. RHT outperforms 100.00% of its industry peers.
  • A Quick Ratio of 1.79 indicates that RHT should not have too much problems paying its short term obligations.
  • RHT has a Quick ratio of 1.79. This is amongst the best in the industry. RHT outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.79
RHT.CA Yearly Current Assets VS Current LiabilitesRHT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. RHT.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 94.41% over the past year.
  • RHT shows a strong growth in Revenue. In the last year, the Revenue has grown by 119.37%.
  • RHT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 115.82% yearly.
EPS 1Y (TTM)94.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.44%
Revenue 1Y (TTM)119.37%
Revenue growth 3Y260.91%
Revenue growth 5Y115.82%
Sales Q2Q%88.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 68.33% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, RHT will show a very strong growth in Revenue. The Revenue will grow by 126.89% on average per year.
EPS Next Y123.08%
EPS Next 2Y64.08%
EPS Next 3Y68.33%
EPS Next 5YN/A
Revenue Next Year106.52%
Revenue Next 2Y102.94%
Revenue Next 3Y126.89%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
RHT.CA Yearly Revenue VS EstimatesRHT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
RHT.CA Yearly EPS VS EstimatesRHT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2023 2024 2025 0 0.05 -0.05 0.1

More info and screens

Find the best growth stocksShow best growing peers

4

4. RHT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • RHT is valuated cheaply with a Price/Forward Earnings ratio of 6.96.
  • 100.00% of the companies in the same industry are more expensive than RHT, based on the Price/Forward Earnings ratio.
  • RHT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.96
RHT.CA Price Earnings VS Forward Price EarningsRHT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RHT.CA Per share dataRHT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

  • RHT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • RHT's earnings are expected to grow with 68.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.08%
EPS Next 3Y68.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RHT.CA Dividend Analysis

5.1 Amount

  • No dividends for RHT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

RHT.CA Fundamentals: All Metrics, Ratios and Statistics

RELIQ HEALTH TECHNOLOGIES IN

TSX-V:RHT (1/16/2024, 7:00:00 PM)

0.215

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.56M
Revenue(TTM)14.62M
Net Income(TTM)-457.61K
Analysts84.44
Price Target1.79 (732.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.96
P/S 2.84
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 3.1
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.03
Fwd EY14.37%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.08
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -3.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.61%
FCFM N/A
ROA(3y)-277.14%
ROA(5y)-257.7%
ROE(3y)-803.99%
ROE(5y)-598.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y143.2%
GM growth 5Y26.85%
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.79
Altman-Z 0.13
F-Score2
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.44%
EPS Next Y123.08%
EPS Next 2Y64.08%
EPS Next 3Y68.33%
EPS Next 5YN/A
Revenue 1Y (TTM)119.37%
Revenue growth 3Y260.91%
Revenue growth 5Y115.82%
Sales Q2Q%88.51%
Revenue Next Year106.52%
Revenue Next 2Y102.94%
Revenue Next 3Y126.89%
Revenue Next 5YN/A
EBIT growth 1Y84.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.4%
EBIT Next 3Y80.52%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.01%
OCF growth 3YN/A
OCF growth 5YN/A

RELIQ HEALTH TECHNOLOGIES IN / RHT.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RELIQ HEALTH TECHNOLOGIES IN?

ChartMill assigns a fundamental rating of 4 / 10 to RHT.CA.


Can you provide the valuation status for RELIQ HEALTH TECHNOLOGIES IN?

ChartMill assigns a valuation rating of 4 / 10 to RELIQ HEALTH TECHNOLOGIES IN (RHT.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for RELIQ HEALTH TECHNOLOGIES IN?

RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) has a profitability rating of 2 / 10.


What is the financial health of RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) stock?

The financial health rating of RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) is 4 / 10.